000 | 01291 a2200337 4500 | ||
---|---|---|---|
005 | 20250513151321.0 | ||
264 | 0 | _c19990222 | |
008 | 199902s 0 0 eng d | ||
022 | _a0586-7614 | ||
024 | 7 |
_a10.1093/oxfordjournals.schbul.a033333 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aYoung, C R | |
245 | 0 | 0 |
_aManagement of the adverse effects of clozapine. _h[electronic resource] |
260 |
_bSchizophrenia bulletin _c1998 |
||
300 |
_a381-90 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAgranulocytosis _xchemically induced |
650 | 0 | 4 |
_aAntipsychotic Agents _xadministration & dosage |
650 | 0 | 4 |
_aCardiovascular Diseases _xchemically induced |
650 | 0 | 4 |
_aCentral Nervous System Diseases _xchemically induced |
650 | 0 | 4 |
_aClozapine _xadministration & dosage |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 |
_aDyskinesia, Drug-Induced _xprevention & control |
650 | 0 | 4 |
_aGastrointestinal Diseases _xchemically induced |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
700 | 1 | _aBowers, M B | |
700 | 1 | _aMazure, C M | |
773 | 0 |
_tSchizophrenia bulletin _gvol. 24 _gno. 3 _gp. 381-90 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/oxfordjournals.schbul.a033333 _zAvailable from publisher's website |
999 |
_c9684009 _d9684009 |